Navigation Links
Study Confirms: Your Hidden Food Allergies Are Making You Fat
Date:4/6/2009

Researchers confirm the benefit of The ALCAT Test to help chronic symptoms such as obesity, IBS, migraine and arthritis.

DEERFIELD BEACH, Fla., April 6 /PRNewswire/ -- Medical researchers from Dubai today reported in the April '09 edition of the Middle East Journal of Family Medicine (The Effect of The ALCAT Test Diet Therapy for Food Sensitivity in Patient's With Obesity) that patients unable to achieve goal weight loss by calorie restriction alone were significantly aided in their attempts when they avoided foods that had been shown by a unique lab test to excite their immune response. The authors, led by Dr. M. Akmal of the Dubai Specialized Medical Centre, pointed out that hidden food allergies, or food sensitivities, are unique to each individual and can cause inflammatory diseases, and an inability to lose weight. Food sensitivities often provoke delayed and chronic symptoms, like IBS, migraine and arthritis, that are not as obvious as the dramatic and immediate onset of "true" food allergies, such as peanut anaphylaxis, but, over the long term, can be just as devastating and are more difficult to detect.

In the course of the 12 week study, the 27 refractory weight loss patients underwent a single treatment: avoidance of foods that were shown to be immune reactive according to blood testing through a system known as the ALCAT test. The study participants showed an average weight loss of approximately 37 pounds plus an average drop of six points of BMI (body mass index) and an average decrease of 30% of body fat.

Dr. Fred Pescatore, former Medical Director of the famed Atkins Center and a pioneer in the study of the hormonal and immune system effects of foods, reviewed the findings and said, "I'm not surprised by these results, dramatic as they may appear. I've used the ALCAT test with my difficult patients time and time again, and it always works."

Other studies based on the elimination of food sensitivities had previously been reported. In a Baylor Medical College study 98% of subjects also displayed significant improved body composition and/or scale weight following an ALCAT test-based food elimination diet within four weeks. A matched control group that followed calorie restriction alone actually became fatter.

"When I first began to lecture to health professionals about how avoidance of food sensitivities helped the weight loss process, people looked at me like I had two heads," says Roger Deutsch, co-author of the book, Your Hidden Food Allergies are Making You Fat. "Now we know that chronic inflammation, caused primarily by exposure to incompatible foods, is at the root of metabolic problems like diabetes, cardiovascular disease and obesity. The immune system chemicals block insulin receptors; so, guess what happens to the sugars we eat? - they get stored as fat. Cut the inflammation, cut the fat storage."

Along with avoidance of food sensitivities, Deutsch and other experts also recommend paying attention to the quality of food eaten, getting adequate rest, exercise, and a healthy lifestyle.

About Cell Science Systems

Cell Science Systems (CSS) is a life sciences company and the worldwide market leader in food sensitivity testing as the maker of The ALCAT Test. ALCAT identifies cellular reactions to over 300 foods and chemicals. These inflammatory reactions are linked to chronic health problems like obesity and diabetes, as well as skin, heart, joint, and digestive disorders. Located in Deerfield Beach, Florida, CSS is a FDA-inspected and registered, cGMP medical device manufacturer and operates a CLIA-certified laboratory. For more information, please call 1-800-US-ALCAT or visit www.ALCAT.com.

For more information, please call 1-800-US-ALCAT or visit http://www.ALCAT.com

This press release was issued through 24-7PressRelease.com. For further information, visit http://www.24-7pressrelease.com.


'/>"/>
SOURCE Cell Science Systems
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Torax Medical Launches Pivotal Clinical Study of New Acid Reflux Treatment
2. Landmark Study in The New England Journal of Medicine Shows HPV Testing Significantly Reduces Deaths from Cervical Cancer, Compared to other Methods Including Pap
3. Major Restless Legs Study Completes Enrollment With Support From MediciGlobal
4. Corgenix AspirinWorks(R) Test Recognized in POLYCAP Study at ACC.09
5. QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy
6. New Study Suggests Rx Estrogen Delivery Through the Skin May Show Safety Benefits as Opposed to Oral Delivery
7. Exenatide Once Weekly Provided Superior Glucose Control With Weight Loss Compared to Sitagliptin or Pioglitazone in Head-to-Head DURATION-2 Study
8. Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)
9. First Human Study to Show Sun Chlorella A Supports Heart Health
10. Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders
11. Lilly Announces Inconclusive Phase II Study Results for mGlu2/3 at the International Congress on Schizophrenia Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... , April 27, 2016 Tie-up ... initiative to save newborns   ... women & newborns in collaboration with Breast Milk Foundation (BMF), ... first Pasteurized Human Milk Bank, ,Amaara, in Delhi-NCR today. This ... food source for infants and should be available to babies ...
(Date:4/27/2016)... Oasmia Pharmaceutical AB (NASDAQ: ... new generation of drugs within human and veterinary ... Paclical/Apealea in the Phase III study that included ... cancer. These preliminary results showed non-inferiority between the ... versus Taxol in combination with carboplatin. In fact, ...
(Date:4/26/2016)... , April 26, 2016 Diplomat Pharmacy, Inc. ... Jennifer Hagerman , Pharm D., to Vice President ... role at Diplomat, Hagerman will continue to lead and ... that delivers custom education and training to Diplomat employees ... pharmacy industry. Diplomat University also houses the quality assurance ...
Breaking Medicine Technology:
(Date:4/28/2016)... ... April 28, 2016 , ... ... and Collaboration Platform™ , today announced a new Residency Education & Collaboration ... to medical knowledge, educational resources, and a host of collaboration tools designed ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... been named a Top Doc in Physical Medicine and Rehabilitation by Philadelphia Magazine. ... Connolly Medical, Ltd. by randomly surveying physicians and medical leadership across the country. ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... announced it will demonstrate its leading secure mobility workstation suite, SentinelSecure™, at MobileIron’s ... at Hilton Union Square, this will be MobileIron’s 6th Mobile First Conference and ...
(Date:4/28/2016)... (PRWEB) , ... April 28, 2016 , ... The ... Prevention (CDC) has established an ICD-10-CM code for sarcopenia, giving it recognition for separate ... medical community effective October 1, 2016. , Sarcopenia is defined as a combination of ...
(Date:4/28/2016)... ... April 28, 2016 , ... Boston Laser is now ... Drug Administration (FDA). The treatment consists of the application of Riboflavin, a vitamin, to ... fibers which in turn strengthens the cornea to slow the progression of keratoconus. , ...
Breaking Medicine News(10 mins):